Literature DB >> 1639436

Viral escape from immune recognition: multiple strategies of adenoviruses.

A Müllbacher1.   

Abstract

Human adenoviruses can cause persistent infections in man. The strategies of C type adenoviruses (types Ad2 and Ad5) to evade immune recognition are many, but all involve single early genetic regions (E3). Gene(s) within E3 have been shown to allow the adenovirus to avert cytokine-mediated apoptosis. Furthermore, the E3 region controls the cytotoxic T cell epitope (a major histocompatibility complex [MHC] class I molecule with an adenovirus-derived peptide) on the cell surface of infected cells. On the one hand the E3 gene product 19 kDa can bind to nascent class I MHC in the endoplasmic reticulum and thus prevent its transport to the cell surface, and on the other hand the E3 region down-regulates the E1a gene product, the immunodominant cytotoxic T cell determinant.

Entities:  

Mesh:

Year:  1992        PMID: 1639436     DOI: 10.1038/icb.1992.9

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  4 in total

1.  Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene.

Authors:  J Schaack; X Guo; S J Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

2.  Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells.

Authors:  Ricardo Camargo; Liliam O Faria; Alexander Kloss; Cecília B F Favali; Ulrike Kuckelkorn; Peter-Michael Kloetzel; Cezar Martins de Sá; Beatriz D Lima
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 3.  Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity.

Authors:  M Lobigs; R V Blanden; A Müllbacher
Journal:  Immunol Rev       Date:  1996-08       Impact factor: 12.988

Review 4.  Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics.

Authors:  Anne S De Groot; Frances Terry; Leslie Cousens; William Martin
Journal:  Expert Rev Clin Pharmacol       Date:  2013-11       Impact factor: 5.045

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.